RE
RELV.US Reliv International Inc
- Market cap
- USD 2.04M
- P/E
- -
- P/B
- 0.61x
- ROE
- -14.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is RELV.US undervalued?
Graham numberThe Graham number of Reliv International Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Reliv International Inc fundamental analysis
No fundamental analysis for Reliv International Inc yet.
Reliv International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Reliv International Inc
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid's nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune support products. It also provides multivitamins, omega 3s, probiotics, weight management, dairy and soy free, vegetarian…
Full company profileReliv International Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Reliv International Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 45.5M | 41.8M | 36.1M | 35.1M | 35.6M | 32.6M | 27.6M | 24.5M | 21.0M | 20.5M | 19.9M |
| Gross Profit | 19.4M | 17.7M | 14.7M | 14.2M | 14.4M | 13.2M | 11.4M | 10.6M | 9.27M | 8.99M | 9.13M |
| Operating Income | -812K | -183K | -1.86M | -559K | 163K | -333K | -1.83M | -1.71M | -2.01M | -1.67M | -1.01M |
| EBITDA | 475K | 857K | -899K | 655K | 1.91M | 463K | -1.06M | 3.15M | -1.60M | -1.32M | -519K |
| Net Income | -625K | -697K | -1.90M | -444K | 1.33M | -440K | -1.96M | 2.51M | -1.93M | -1.55M | -839K |
| EPS | -0.34 | -0.38 | -1.03 | -0.25 | 0.76 | -0.41 | -1.85 | 2.38 | -1.83 | -1.43 | -0.74 |
| Balance Sheet | |||||||||||
| Total Assets | 22.5M | 21.1M | 16.4M | 15.3M | 19.7M | 16.2M | 13.6M | 14.3M | 12.6M | 10.6M | 10.1M |
| Total Liabilities | 7.55M | 6.71M | 4.36M | 4.21M | 7.26M | 6.82M | 6.32M | 4.40M | 4.72M | 4.07M | 4.12M |
| Shareholders' Equity | 14.9M | 14.4M | 12.0M | 11.1M | 12.5M | 9.37M | 7.29M | 9.88M | 7.84M | 6.49M | 6.00M |
| Cash & Short-term Investments | 3.61M | 3.27M | 1.99M | 1.63M | 7.03M | 4.34M | 2.45M | 5.67M | 4.73M | 3.58M | 3.44M |
| Total Debt | 2.91M | 3.05M | - | 840K | 4.01M | 3.92M | 3.78M | 2.70M | 2.55M | 2.43M | 2.37M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.53M | -157K | -1.17M | -943K | 1.12M | -750K | -1.77M | -1.23M | -821K | -1.49M | -461K |
| Capital Expenditure | 174K | 499K | 181K | 98.8K | 34.6K | 54.3K | 88.3K | 308K | 279K | 92.7K | 23.7K |
| Free Cash Flow | 1.35M | -656K | -1.35M | -1.04M | 1.09M | -804K | -1.86M | -1.54M | -1.10M | -1.58M | -485K |
| Ratios | |||||||||||
| ROE | -4.2% | -4.9% | -15.9% | -4.0% | 10.7% | -4.7% | -26.8% | 25.4% | -24.6% | -23.9% | -14.0% |
| ROA | -2.8% | -3.3% | -11.6% | -2.9% | 6.7% | -2.7% | -14.4% | 17.6% | -15.4% | -14.7% | -8.3% |
| Net Profit Margin | -1.4% | -1.7% | -5.3% | -1.3% | 3.7% | -1.4% | -7.1% | 10.2% | -9.2% | -7.5% | -4.2% |
| Debt to Equity | 0.19x | 0.21x | - | 0.08x | 0.32x | 0.42x | 0.52x | 0.27x | 0.33x | 0.37x | 0.40x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Reliv International Inc dividends
Reliv International Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:7 on Oct 4, 2016.
Who owns Reliv International Inc
Top funds holding RELV.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Bridgeway Ultra-Small Company | 26.9K | 1.54% | 0.00% | Sep 2020 |
| Fidelity® Extended Market Index | 1.50K | 0.09% | 0.00% | Nov 2020 |
| NT Ext Equity Mkt Idx Fd - L | 1.49K | 0.09% | +11,376.92% | Dec 2020 |
| SSgA U.S. Extended Market Index Class I | 399.00 | 0.02% | 0.00% | Dec 2020 |
| State St US Extended Mkt Indx NL Cl C | 399.00 | 0.02% | 0.00% | Dec 2020 |
| NT Quality Small Cap Core | 290.00 | 0.02% | 0.00% | Sep 2020 |
| NT Quality SCC US Fund - L | 290.00 | 0.02% | 0.00% | Dec 2020 |
| NT US Market Cap Idx Fd - L | 222.00 | 0.01% | 0.00% | Dec 2020 |
| Northern Trust Wilshire 5000 | 222.00 | 0.01% | 0.00% | Jun 2020 |
| USAA Extended Market Index | 205.00 | 0.01% | +8.47% | Dec 2020 |
| Fidelity® NASDAQ Composite Index® | 131.00 | 0.01% | 0.00% | Nov 2020 |
| SSgA U.S. Total Market Index Strategy | 121.00 | 0.01% | +65.75% | Dec 2020 |
| NT Ext Equity Mkt Idx Fd - NL | 84.00 | 0.00% | 0.00% | Dec 2020 |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 59.00 | 0.00% | -3.28% | Dec 2020 |
| Spartan Extended Market Index Pool E | 28.00 | 0.00% | 0.00% | Nov 2020 |
| Northern Trust Extended Eq Market Idx | 13.00 | 0.00% | 0.00% | Jun 2020 |
| Vanguard Extended Market Index Investor | 0.00 | 0.00% | -100.00% | Dec 2020 |
| iShares Core S&P Total US Stock Mkt ETF | 0.00 | 0.00% | -100.00% | Dec 2020 |
Top institutions holding RELV.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Renaissance Technologies Corp | 103K | 5.89% | -0.87% | Sep 2020 |
| Bridgeway Capital Management, Inc | 26.9K | 1.54% | 0.00% | Sep 2020 |
| FLAGSHIP HARBOR ADVISORS, LLC | 3.62K | 0.21% | -44.33% | Sep 2020 |
| Morgan Stanley - Brokerage Accounts | 600.00 | 0.03% | 0.00% | Sep 2020 |
| UBS Group AG | 429.00 | 0.02% | 0.00% | Sep 2020 |
| BlackRock Inc | 258.00 | 0.01% | 0.00% | Sep 2020 |
| MBM Wealth Consultants, LLC | 114.00 | 0.01% | 0.00% | Jun 2020 |
| TSFG, LLC | 45.00 | 0.00% | 0.00% | Sep 2020 |
| Advisor Group Holdings, Inc. | 14.00 | 0.00% | 0.00% | Sep 2020 |
| Wells Fargo & Co | 9.00 | 0.00% | 0.00% | Sep 2020 |
| Bank of America Corp | 8.00 | 0.00% | 0.00% | Jun 2020 |
| Victory Capital Management Inc. | 0.00 | 0.00% | -100.00% | Jun 2020 |
Reliv International Inc company profile
- Company name
- Reliv International Inc
- Ticker
- RELV.US
- Exchange
- USA Stocks
- Listed since
- Mar 15, 1993
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 91
- Fiscal year end
- December
- Address
- 136 Chesterfield Industrial Boulevard, Chesterfield, MO, United States, 63005
- Phone
- 800 735 4887
- Website
- reliv.com
About Reliv International Inc
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid's nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune support products. It also provides multivitamins, omega 3s, probiotics, weight management, dairy and soy free, vegetarian, and vegan products. The company offers its products under the fibrestore, Reliv Classic, Innergize!, and LunaRich C brands. It operates in the United States, Canada, Mexico, the United Kingdom, Ireland, Germany, Australia, New Zealand, the Philippines, Malaysia, Singapore, Austria, the Netherlands, and France. The company was founded in 1988 and is headquartered in Chesterfield, Missouri.
Reliv International Inc management
8- Mr. Robert L. MontgomeryCo-Founder & Chairman · born 1942
- Mr. Ryan A. Montgomery J.D.CEO & Director · born 1974
- Mr. Steven D. Albright CPASenior VP & CFO · born 1962
- Ms. Debra P. BernardoniSenior VP & COO · born 1971
- Mr. Stephen M. Merrick J.D.General Counsel & Secretary · born 1942
- Dr. Alfredo GalvezChief Scientific Advisor
- Ms. Michelle Robles-DevnaniManaging Director of Reliv Philippines
- Ms. Kerri ToyManaging Director of Reliv Europe